A 2025 systematic review in orthopaedic sports medicine noted that most evidence remains preclinical, but the peptide showed promising findings in muscle, tendon, ligament, and bony injury models
Product insert: OZEMPIC (semaglutide) injection, for subcutaneous use initial U.S
However, effectiveness depends on your dose, medical history, side effects, and lifestyle changes
Visceral Adipose Tissue Reduction (Phase III)~15% IGF-1 Level Increase~100% Trunk Fat Area Reduction~18% Lean Body Mass PreservationMaintained Figures are representative of published research findings and shown for reference
Solutions like dedicated GLP-1 tracking apps centralize: Medication timing Meal composition Hydration Side-effect visualization So users find whether reflux clusters around certain foods, post-fast large meals, or specific dose timings, and can bring precise data to their clinician, shortening the path from confusion to targeted changes
How fast should the dose be escalated